ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹922 Cr | ₹819 Cr | ₹666 Cr | ₹560 Cr | ₹450 Cr |
What is the latest Revenue of ORCHID PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹922 Cr |
| Mar2024 | ₹819 Cr |
| Mar2023 | ₹666 Cr |
| Mar2022 | ₹560 Cr |
| Mar2021 | ₹450 Cr |
How is Revenue of ORCHID PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹922 Cr | 12.52 | |
| Mar2024 | ₹819 Cr | 23.05 | |
| Mar2023 | ₹666 Cr | 19.00 | |
| Mar2022 | ₹560 Cr | 24.33 | |
| Mar2021 | ₹450 Cr | - | |
Compare Revenue of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,000.5 Cr | -3.5% | 2.4% | 34.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -3.5% |
2.4% |
34.9% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses